Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Vertex Pharmaceuticals Incorporated
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Arcturus Therapeutics: === Valued at $898.xmillion, revenue for FY 2022 $206 million and net income $9.3 million. Arcturus Therapeutics is an active preclinical drug delivery and nucleic acid medicines company that specializes in developing cutting-edge technologies for RNA and DNA medicines. With a strong focus on innovation, the company is dedicated to advancing the field of nucleic acid therapeutics. Arcturus Therapeutics was formed through a merger between Arcturus Therapeutics and Alcobra, bringing together their expertise and resources to drive groundbreaking advancements in drug delivery and nucleic acid-based treatments. As a public company founded in 2013, Arcturus Therapeutics remains committed to making a significant impact on the medical landscape by providing potential solutions for various diseases through the application of nucleic acid medicines. Headquartered in San Diego, CA, Arcturus Therapeutics continues to lead the way in the development of transformative therapies for patients worldwide.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
